[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-402175-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-402175-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","getting-hiv-prevention-on-track-to-attain-2030-targets-conference-abstract","Getting HIV Prevention on Track to Attain 2030 Targets - Conference Abstract","","July 22, 2024 Munich presentation content outlines progress to reach 2030 HIV prevention targets through PrEP in France. It summarizes PrEP as a prevention tool for adults and adolescents at increased risk, supported by current guidance, community involvement, and integrated delivery into existing services. It reports how French National Health Data (SNDS) was used to describe PrEP users and initiation patterns from 2016–2023, including regional distribution, uptake, retention gaps, and prescribing roles. It concludes with a reference to the EPIPHARE report.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/getting-hiv-prevention-on-track-to-attain-2030-targets-conference-abstract/402175/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/getting-hiv-prevention-on-track-to-attain-2030-targets-conference-abstract/402175.png","ImageObject",300,407,{"name":42,"@type":43},"BigDaveOnline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-27",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is PrEP described as in the guidance?","Question",{"text":62,"@type":63},"PrEP is presented as a tool to prevent HIV infection in adults and adolescents exposed to HIV. It uses an individualized discussion to assess past and future exposures and determine eligibility for shared decision-making.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Which groups are listed as having an increased risk suitable for discussion about PrEP?",{"text":67,"@type":63},"The document lists MSM and transgender women or men, heterosexual men and women in settings with high HIV prevalence (including high endemic countries, multiple partners, condomless sex, use of PEP, STIs), and people who inject drugs sharing syringes.",{"name":69,"@type":60,"acceptedAnswer":70},"How is PrEP delivery integrated into existing services in France?",{"text":71,"@type":63},"Delivery is integrated through hospital-based HIV clinics and STI clinics, with GP involvement for renew prescriptions and initiation. PrEP is delivered in hospital settings or via private pharmacies.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},402175,1791321033,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,109,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":107,"slug":108},7,40,"healthcare",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},8,"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":106,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},962090896214,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","July 22, 2024 Munich, Germany  \nGetting HIV Prevention on Track to Attain 2030 Targets  \nThe City of Paris  \nJean-Michel Molina, MD  \nUniversity of Paris Cité and Department of Infectious Diseases , St-Louis and Lariboisière Hospitals , Paris, France  \nPrEP is Changing HIV Prevention  \nJanuary 1st 2016  \nOral PrEP with TDF/FTC Approved in France  \nStrong Community Involvement  \nCity Hall Meeting, Paris, February 2016  \nCurrent PrEP Guidelines  \n• PrEP is a tool to prevent HIV infection in adults and adolescents exposed to HIV  \n• Individualized approach assessing past and future exposures to identify eligible persons  \n• People exposed to an increased risk of HIV acquisition:  \n• MSM and transgender women or men  \n• Heterosexuals men and women in a context of high HIV prevalence: high endemic countries, multiple partners, condomless sex, use of PEP, STIs…  \n• IVDU sharing syringes  \n• Indications are not selection criteria but help guide the discussion with the patient to make a shared decision about PrEP initiation  \n• PrEP not indicated for a stable couple when HIV-positive partner has undetectable viral load  \nHaute Autorité de Santé April 2021  \nPrEP Delivery Integrated into Existing Services in France  \n• Hospital-based HIV clinics (01/2016)   \n• STI clinics (06/2016)   \n• GP renew prescriptions (2017) and initiate (6/21)  \n• PrEP delivered in hospital or private pharmacies  \nRoll-out of HIV PrEP with TDF/FTC  \nin France (2016-2023)  \n• Using the French National Health Data System (SNDS) covering 99% of people in France from January 1st 2016 to June 30, 2023  \n• PrEP users defined as individuals > 15 years , HIV negative , and who received at least one dispensing of TDF/FTC  \n• 97% are men with a median age of 34 years (IQR:27-44)  \n• 41% live in the Ile de France region (23% in Paris) , 10% in Auvergne-Rhone-Alpes and 9% in French Riviera, only 1,5% overseas departments  \n• 84,997 individuals have initiated PrEP since January 2016 (1559 initiations per month in 2022) and 52,800 are still using PrEP in 2023  \n• Up to 23% of new PrEP users have no prescription renewal in following 6 months  \n• Only 27% of PrEP initiations are prescribed by private practioners and 31% of renewals  \nAdapted from EPIPHARE report 11/2023  \nPrEP in France Today  \nBilloti de Gage S, Desplas D, Dray-Spira R Epiphare November 2023","cbCaiabrg7Jc0Dzv","https://ap.wps.com/l/cbCaiabrg7Jc0Dzv","pdf",2750779,23,"English","# PrEP is Changing HIV Prevention\n## Current PrEP Guidelines\n## PrEP Delivery in France\n## Roll-out and Data from SNDS (2016-2023)\n## PrEP in France Today","[{\"question\":\"What is PrEP described as in the guidance?\",\"answer\":\"PrEP is presented as a tool to prevent HIV infection in adults and adolescents exposed to HIV. It uses an individualized discussion to assess past and future exposures and determine eligibility for shared decision-making.\"},{\"question\":\"Which groups are listed as having an increased risk suitable for discussion about PrEP?\",\"answer\":\"The document lists MSM and transgender women or men, heterosexual men and women in settings with high HIV prevalence (including high endemic countries, multiple partners, condomless sex, use of PEP, STIs), and people who inject drugs sharing syringes.\"},{\"question\":\"How is PrEP delivery integrated into existing services in France?\",\"answer\":\"Delivery is integrated through hospital-based HIV clinics and STI clinics, with GP involvement for renew prescriptions and initiation. PrEP is delivered in hospital settings or via private pharmacies.\"}]","Getting HIV Prevention on Track to Attain 2030 Targets - Conference Abstract | PDF",1790527709,58]